David R Nelson

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 5

Top Topics

Human Immunodeficiency Virus

Replacement Therapy

Patient Reported

Top Venues

Hepatology (Baltimore, Md.)

Hepatology communications

This page only lists publications with an associated author ORCID identifier.

Publications

Haesuk Park, Wei-Hsuan Lo-Ciganic, James Huang, Yonghui Wu, Linda Henry, Joy Peter, Mark S Sulkowski, David R Nelson
Machine learning algorithms for predicting direct-acting antiviral treatment failure in chronic hepatitis C: An HCV-TARGET analysis. Hepatology (Baltimore, Md.) 76 (2) (2022)
Haesuk Park, Xinyi Jiang, Hyun Jin Song, Vincent Lo Re, Lindsey M Childs-Kean, Wei-Hsuan Lo-Ciganic, Robert L Cook, David R Nelson
The Impact of Direct-Acting Antiviral Therapy on End-Stage Liver Disease Among Individuals with Chronic Hepatitis C and Substance Use Disorders. Hepatology (Baltimore, Md.) 74 (2) (2021)
Haesuk Park, Hyun Jin Song, Xinyi Jiang, Linda Henry, Robert L Cook, David R Nelson
Direct-Acting Antiviral Treatment Use Remains Low Among Florida Medicaid Beneficiaries With Chronic Hepatitis C. Hepatology communications 5 (2) (2020)
Haesuk Park, Wei Wang, Linda Henry, David R Nelson
Impact of All-Oral Direct-Acting Antivirals on Clinical and Economic Outcomes in Patients With Chronic Hepatitis C in the United States. Hepatology (Baltimore, Md.) 69 (3) (2019)
Donna M Evon, Paul W Stewart, Jipcy Amador, Marina Serper, Anna S Lok, Richard K Sterling, Souvik Sarkar, Carol E Golin, Bryce B Reeve, David R Nelson, Nancy Reau, Joseph K Lim, K Rajender Reddy, Adrian M Di Bisceglie, Michael W Fried
A comprehensive assessment of patient reported symptom burden, medical comorbidities, and functional well being in patients initiating direct acting antiviral therapy for chronic hepatitis C: Results from a large US multi-center observational study. PloS one 13 (8) (2018)